The Effect of Menstrual Cycle Phase and Protein Dose on Muscle Protein Synthesis
NCT ID: NCT05178732
Last Updated: 2024-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2022-01-16
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Muscle recovery is related to the ability to build new muscle protein from amino acids (muscle protein synthesis). This response is thought to be impacted in females by hormones that fluctuate across different phases of the menstrual cycle. However, the effect of menstrual cycle phase on muscle protein synthesis is not known.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Menstrual Cycle Phase on Muscle Protein Synthesis
NCT06268678
Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise
NCT07258576
Protein Requirements in Male and Female Endurance Athletes
NCT04855474
The Impact of Enteral Versus Oral Protein Feeding on Muscle Protein Synthesis in Healthy Young Males and Females
NCT03571425
Exogenous Ketosis and Muscle Protein Synthesis During Exercise Recovery
NCT06769100
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Protein dose 1 and early
Dose of protein
One of three protein doses provided
Menstrual cycle phase
Different phase of the menstrual cycle
Protein dose 1 and late
Dose of protein
One of three protein doses provided
Menstrual cycle phase
Different phase of the menstrual cycle
Protein dose 2 and early
Dose of protein
One of three protein doses provided
Menstrual cycle phase
Different phase of the menstrual cycle
Protein dose 2 and late
Dose of protein
One of three protein doses provided
Menstrual cycle phase
Different phase of the menstrual cycle
Protein dose 3 and early
Dose of protein
One of three protein doses provided
Menstrual cycle phase
Different phase of the menstrual cycle
Protein dose 3 and late
Dose of protein
One of three protein doses provided
Menstrual cycle phase
Different phase of the menstrual cycle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dose of protein
One of three protein doses provided
Menstrual cycle phase
Different phase of the menstrual cycle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Recreationally active
* Regular menstrual cycle
Exclusion Criteria
* Metabolic disease
* Any motor disorder
* Use of over-the-counter pharmaceuticals, during the study.
* Pomegranate, milk or lidocaine allergy
* Taken contraceptives in the past 3 months
* Irregular menstrual cycle (less than 9 cycles per year and a length not between 21-35 days)
* Post-menopausal women
* Pregnancy and lactation
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
P.volve
UNKNOWN
University of Exeter
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Francis Stephens
Role: PRINCIPAL_INVESTIGATOR
University of Exeter
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Exeter
Exeter, Devon, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-10-20-B-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.